Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Business Roundup

January 1, 2007 | A version of this story appeared in Volume 85, Issue 1

QLT Inc. has entered a two-year agreement with the Wilmer Eye Institute at Johns Hopkins University to research treatments for age-related macular degeneration. QLT has the option to negotiate an exclusive license to products resulting from the collaboration.

Genentech has licensed ALTU-238, a once-weekly formulation of human growth hormone developed using Altus Pharmaceuticals' protein crystallization technology. Altus will receive a $15 million fee and could earn up to $140 million in milestone payments. Genentech will also take a $15 million stake in the Cambridge, Mass.-based firm.

The European Commission has cleared two petrochemical deals: Saudi Basic Industries Corp.'s purchase of Huntsman Corp.'s U.K. petrochemicals operations and Basell's purchase of the Münchsmünster, Germany, ethylene cracker from Ruhr Oel, a joint venture between BP and PDVSA.

Teijin Chemicals will increase its Chinese polycarbonate capacity by 60% to 160,000 metric tons per year. A new production line in Jiaxing, Zhejiang province, is scheduled to open in March 2009 at a cost of $92 million.

FMC Corp. and BASF have cross-licensed insecticidal ingredients for the U.S. market. As a result, BASF gains access to FMC's zeta-cypermethrin, and FMC can use BASF's pendimethalin and imazethapyr.

Albemarle has created a new alternative fuel technologies division. It will focus on developing catalysts for oil sands, coal-to-liquids, and biomass-to-fuel technologies.

ICI's National Starch unit is building a $20 million emulsion polymers unit in Shanghai's Songjiang Industrial Development Zone. The plant is scheduled for completion in mid-2007. The company recently announced a technical center and a construction polymers plant for China.

Japan's Itochu will spend $8.5 million to acquire a 4% stake in NorSun, a company launched in December 2005 by Alf Bjorseth, the former CEO of Renewable Energy, a Norwegian producer of solar-grade silicon. NorSun plans to build a silicon wafer plant in Ardal, Norway.

Advertisement

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.